Tokyo, September 18, 2020: Eisai Co., Ltd. has announced that the latest results from the cohort targeting patients with HER2-negative…
New Delhi, May 17, 2020: Eisai Co., Ltd. announced today that presentations on a series of abstracts regarding its in-house…
TECERIS® aimed at expanding access to metastatic breast cancer patients in India Vishakhapatnam, September 29, 2019: Eisai Pharmaceuticals India Pvt.…
Aiming to Expand Availability of Eribulin to Patients in India with Two Brands Halaven and Teceris Tokyo, September 21, 2019: …